About this trial
This single-center randomized controlled trial evaluates whether detecting the first lymph node at the axillary entrance with ultrasound guidance, followed by a targeted axillary incision over the pencil-marked projection, improves sentinel lymph node identification compared to the conventional axillary hairline landmark. The study hypothesizes that this technique enables a smaller incision, minimizes tissue dissection, and reduces operative time.
Eligibility criteria
Qualifiers
* Patients with clinical stage T1-T3 disease (tumor ≤5 cm), pN0-pN1 (one to three regional lymph nodes with micrometastases or metastases), and M0 (no distant metastasis) are eligible. Post-neoadjuvant yT1-T3, yN0-yN1, and M0 status are also eligible. All patients are undergoing axillary staging.
Clinically negative axilla
Written informed consent must be obtained prior to inclusio
Disqualifiers
Younger than 18 years
Previous breast malignancy
Pregnancy
Pre-operative diagnosis of axillary lymph node metastases
Trial design
Treatments tested in this trial
- Ultrasound-guided axillary incision group
- The standard axillary incision